Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model
Author
Baines, Simon D.
Noel, Alan R.
Huscroft, Grace S.
Todhunter, Sharie L.
O'Connor, Rachael
Hobbs, Joanne K.
Freeman, Jane
Lovering, Andy M.
Wilcox, M. H.
Attention
2299/10364
Abstract
Therapeutic options in Clostridium difficile infection (CDI) are limited. We examined linezolid activity in vitro and potential therapeutic efficacy using a gut model of CDI.